- Home
- WMK vs CNTA Comparison
WMK vs CNTA Comparison
Compare WMK & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WMK
- CNTA
- Stock Information
- Founded
- WMK 1912
- CNTA 2020
- Country
- WMK United States
- CNTA United Kingdom
- Employees
- WMK N/A
- CNTA N/A
- Industry
- WMK Food Chains
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- WMK Consumer Staples
- CNTA Health Care
- Exchange
- WMK Nasdaq
- CNTA Nasdaq
- Market Cap
- WMK 1.9B
- CNTA 1.9B
- IPO Year
- WMK N/A
- CNTA 2021
- Fundamental
- Price
- WMK $73.02
- CNTA $17.03
- Analyst Decision
- WMK
- CNTA Strong Buy
- Analyst Count
- WMK 0
- CNTA 11
- Target Price
- WMK N/A
- CNTA $28.90
- AVG Volume (30 Days)
- WMK 98.0K
- CNTA 853.6K
- Earning Date
- WMK 08-05-2025
- CNTA 08-12-2025
- Dividend Yield
- WMK 1.86%
- CNTA N/A
- EPS Growth
- WMK 6.00
- CNTA N/A
- EPS
- WMK 3.99
- CNTA N/A
- Revenue
- WMK $4,810,301,000.00
- CNTA $15,000,000.00
- Revenue This Year
- WMK N/A
- CNTA N/A
- Revenue Next Year
- WMK N/A
- CNTA N/A
- P/E Ratio
- WMK $18.38
- CNTA N/A
- Revenue Growth
- WMK 1.23
- CNTA 118.88
- 52 Week Low
- WMK $62.25
- CNTA $9.10
- 52 Week High
- WMK $90.23
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- WMK 41.41
- CNTA 65.73
- Support Level
- WMK $76.17
- CNTA $15.05
- Resistance Level
- WMK $75.52
- CNTA $17.69
- Average True Range (ATR)
- WMK 1.88
- CNTA 0.74
- MACD
- WMK -0.37
- CNTA 0.02
- Stochastic Oscillator
- WMK 7.01
- CNTA 59.70
About WMK Weis Markets Inc.
Weis Markets Inc is a U.S.-based company that is principally engaged in retailing food products in Pennsylvania and surrounding states. The company's products mainly belong to the following categories: center-store goods, fresh goods, pharmacy services, fuel, and others. The center-store goods include groceries, dairy products, frozen foods, alcoholic beverages, and general merchandise items. The fresh goods include meats, seafood, floral, prepared foods, and bakery products. The center-store goods and fresh goods jointly account for the majority of the company's total revenue.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.